title: BCL-2 expression is mainly regulated by JAK/STAT3 pathway in human CD34+ hematopoietic cells.
authors.forename: P
authors.initials: P
authors.lastname: Sepúlveda
authors.forename: A
authors.initials: A
authors.lastname: Encabo
authors.forename: F
authors.initials: F
authors.lastname: Carbonell-Uberos
authors.forename: M D
authors.initials: MD
authors.lastname: Miñana
mesh_terms: D000071916:AC133 Antigen; D000818:Animals; D015703:Antigens, CD / Q000276:immunology; D018952:Antigens, CD34 / Q000276:immunology*; D002469:Cell Separation; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005312:Fetal Blood / Q000166:cytology* / Q000187:drug effects / Q000201:enzymology; D005786:Gene Expression Regulation / Q000187:drug effects; D006023:Glycoproteins / Q000276:immunology; D006801:Humans; D007377:Interleukin-3 / Q000494:pharmacology; D015850:Interleukin-6 / Q000494:pharmacology; D053612:Janus Kinases / Q000037:antagonists & inhibitors / Q000378:metabolism*; D051379:Mice; D010455:Peptides / Q000276:immunology; D019000:Phosphotyrosine / Q000378:metabolism; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000235:genetics* / Q000378:metabolism; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D050796:STAT3 Transcription Factor / Q000378:metabolism*; D019089:Stem Cell Factor / Q000494:pharmacology; D014158:Transcription, Genetic / Q000187:drug effects; D051028:bcl-2-Associated X Protein / Q000235:genetics*
chemical_list: D000071916:AC133 Antigen; D015703:Antigens, CD; D018952:Antigens, CD34; D004791:Enzyme Inhibitors; D006023:Glycoproteins; D007377:Interleukin-3; D015850:Interleukin-6; D010455:Peptides; D019253:Proto-Oncogene Proteins c-bcl-2; D012333:RNA, Messenger; D050796:STAT3 Transcription Factor; D019089:Stem Cell Factor; D051028:bcl-2-Associated X Protein; D019000:Phosphotyrosine; D053612:Janus Kinases